Engineered CRISPR-Cas9 nuclease with expanded targeting space
Hiroshi Nishimasu,Xi Shi,Soh Ishiguro,Linyi Gao,Seiichi Hirano,Sae Okazaki,Taichi Noda,Omar O Abudayyeh,Jonathan S Gootenberg,Hideto Mori,Seiya Oura,Benjamin Holmes,Mamoru Tanaka,Motoaki Seki,Hisato Hirano,Hiroyuki Aburatani,Ryuichiro Ishitani,Masahito Ikawa,Nozomu Yachie,Feng Zhang,Osamu Nureki,Omar O. Abudayyeh,Jonathan S. Gootenberg
DOI: https://doi.org/10.1126/science.aas9129
IF: 56.9
2018-09-21
Science
Abstract:Expanding the targeting space of Cas9 CRISPR-Cas9 associates with a guide RNA to target and cleave a specific DNA site next to a protospacer adjacent motif (PAM). Streptococcus pyogenes Cas9 (SpCas9), the one most often used for genome editing, only recognizes the NGG sequence (where N is any nucleobase) as the PAM, which restricts regions in the genome that can be targeted. To address this limitation, Nishimasu et al. created a SpCas9 variant that recognizes NG rather than NGG. The SpCas9-NG variant increased the targeting range, had a specificity similar to that of the wild-type enzyme, and could be used with a base editor. Thus, SpCas9-NG is a powerful addition to the CRISPR-Cas9 genome engineering toolbox and will be useful in a broad range of applications, from basic research to clinical therapeutics. Science , this issue p. 1259
multidisciplinary sciences